吲哚美辛栓剂对ERCP术后急性胰腺炎的预防作用

发布时间：2018-06-13 02:20

本文选题：逆行性胰胆管造影 + 吲哚美辛　；参考：《医学与哲学(B)》2017年05期

【摘要】：探讨吲哚美辛栓剂对不同种类的高危患者逆行性胰胆管造影(ERCP)术后急性胰腺炎的预防作用,将符合标准的患者按1∶1的比例分为治疗组和对照组,采用亚组分析比较吲哚美辛栓在不同患者中对ERCP术后胰腺炎的预防作用的差异。结果显示,ERCP术后使用吲哚美辛组胰腺炎发生率显著低于对照组。对于胰管置管失败的患者,使用吲哚美辛组胰腺炎发生率低于对照组;对于未尝试胰管置管的患者及置管成功的患者,两组间胰腺炎发生率并无显著差异。提示使用吲哚美辛栓可降低ERCP术后胰腺炎的发生率。对于胰管置管失败患者ERCP术后给予吲哚美辛栓降低术后胰腺炎风险的获益最大。
[Abstract]:To investigate the preventive effect of indomethacin suppository on acute pancreatitis after ERCPG in different high risk patients, the patients who met the criteria were divided into treatment group and control group according to the proportion of 1:1. Subgroup analysis was used to compare the preventive effects of indomethacin suppository on pancreatitis after ERCP in different patients. The results showed that the incidence of pancreatitis in indomethacin group after ERCP was significantly lower than that in control group. The incidence of pancreatitis in the indomethacin group was lower than that in the control group, but there was no significant difference in the incidence of pancreatitis between the two groups. The results suggest that indomethacin suppository can reduce the incidence of pancreatitis after ERCP. Indomethacin was given to patients with failed pancreatic duct placement after ERCP to reduce the risk of pancreatitis.
【作者单位】：锦州医科大学附属第一医院消化内科;
【分类号】：R576

【相似文献】